Funding
Seed · Biotech

ARTAN Bio raises $200K in decentralized research funding

VitaDAO backed work on mutation-specific codon suppression for genetic-disease and longevity research.

Updated Oct 16, 2026By RoundOS Funding desk

VitaDAO supplied the $200,000 backing for ARTAN Bio’s mutation-specific codon-suppression research programme. The June announcement connects decentralized funding with the company’s work on genetic-disease and longevity science.

Funding history

Seed · This round$200K

Sources

  1. ARTAN Bioprojectstartups.com
  2. prnewswire.com

Similar rounds

All Biotech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A · Oct 22, 2026

Related